23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
On January 13, 2020, the U.S. Department of Treasury published final regulations relating to the Com...
Read More >
Yesterday, the full Ninth Circuit held that an employer cannot rely on an individual’s prior salary...
Read More >
On April 2nd, the New York State Assembly and Senate passed the Governor’s budget bill which contai...
Read More >
On April 27, Texas Governor Greg Abbott announced his plan for beginning to reopen businesses in Tex...
Read More >
Connecticut has followed a growing trend among the states by implementing a system to provide paid t...
Read More >
On Jan. 28, 2020, the Federal Trade Commission announced revised thresholds for pre-merger filings u...
Read More >